Cargando…
Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study
In COVID-19, guidelines recommend a urinalysis on hospital admission as SARS-CoV-2 renal tropism, post-mortem, was associated with disease severity and mortality. Following the hypothesis from our pilot study, we now validate an algorithm harnessing urinalysis to predict the outcome and the need for...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306631/ https://www.ncbi.nlm.nih.gov/pubmed/34300217 http://dx.doi.org/10.3390/jcm10143049 |
_version_ | 1783727856948346880 |
---|---|
author | Gross, Oliver Moerer, Onnen Rauen, Thomas Böckhaus, Jan Hoxha, Elion Jörres, Achim Kamm, Matthias Elfanish, Amin Windisch, Wolfram Dreher, Michael Floege, Juergen Kluge, Stefan Schmidt-Lauber, Christian Turner, Jan-Eric Huber, Samuel Addo, Marylyn M. Scheithauer, Simone Friede, Tim Braun, Gerald S. Huber, Tobias B. Blaschke, Sabine |
author_facet | Gross, Oliver Moerer, Onnen Rauen, Thomas Böckhaus, Jan Hoxha, Elion Jörres, Achim Kamm, Matthias Elfanish, Amin Windisch, Wolfram Dreher, Michael Floege, Juergen Kluge, Stefan Schmidt-Lauber, Christian Turner, Jan-Eric Huber, Samuel Addo, Marylyn M. Scheithauer, Simone Friede, Tim Braun, Gerald S. Huber, Tobias B. Blaschke, Sabine |
author_sort | Gross, Oliver |
collection | PubMed |
description | In COVID-19, guidelines recommend a urinalysis on hospital admission as SARS-CoV-2 renal tropism, post-mortem, was associated with disease severity and mortality. Following the hypothesis from our pilot study, we now validate an algorithm harnessing urinalysis to predict the outcome and the need for ICU resources on admission to hospital. Patients were screened for urinalysis, serum albumin (SA) and antithrombin III activity (AT-III) obtained prospectively on admission. The risk for an unfavorable course was categorized as (1) “low”, (2) “intermediate” or (3) “high”, depending on (1) normal urinalysis, (2) abnormal urinalysis with SA ≥ 2 g/dL and AT-III ≥ 70%, or (3) abnormal urinalysis with SA or AT-III abnormality. Time to ICU admission or death served as the primary endpoint. Among 223 screened patients, 145 were eligible for enrollment, 43 falling into the low, 84 intermediate, and 18 into high-risk categories. An abnormal urinalysis significantly elevated the risk for ICU admission or death (63.7% vs. 27.9%; HR 2.6; 95%-CI 1.4 to 4.9; p = 0.0020) and was 100% in the high-risk group. Having an abnormal urinalysis was associated with mortality, a need for mechanical ventilation, extra-corporeal membrane oxygenation or renal replacement therapy. In conclusion, our data confirm that COVID-19-associated urine abnormalities on admission predict disease aggravation and the need for ICU (ClinicalTrials.gov number NCT04347824). |
format | Online Article Text |
id | pubmed-8306631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83066312021-07-25 Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study Gross, Oliver Moerer, Onnen Rauen, Thomas Böckhaus, Jan Hoxha, Elion Jörres, Achim Kamm, Matthias Elfanish, Amin Windisch, Wolfram Dreher, Michael Floege, Juergen Kluge, Stefan Schmidt-Lauber, Christian Turner, Jan-Eric Huber, Samuel Addo, Marylyn M. Scheithauer, Simone Friede, Tim Braun, Gerald S. Huber, Tobias B. Blaschke, Sabine J Clin Med Article In COVID-19, guidelines recommend a urinalysis on hospital admission as SARS-CoV-2 renal tropism, post-mortem, was associated with disease severity and mortality. Following the hypothesis from our pilot study, we now validate an algorithm harnessing urinalysis to predict the outcome and the need for ICU resources on admission to hospital. Patients were screened for urinalysis, serum albumin (SA) and antithrombin III activity (AT-III) obtained prospectively on admission. The risk for an unfavorable course was categorized as (1) “low”, (2) “intermediate” or (3) “high”, depending on (1) normal urinalysis, (2) abnormal urinalysis with SA ≥ 2 g/dL and AT-III ≥ 70%, or (3) abnormal urinalysis with SA or AT-III abnormality. Time to ICU admission or death served as the primary endpoint. Among 223 screened patients, 145 were eligible for enrollment, 43 falling into the low, 84 intermediate, and 18 into high-risk categories. An abnormal urinalysis significantly elevated the risk for ICU admission or death (63.7% vs. 27.9%; HR 2.6; 95%-CI 1.4 to 4.9; p = 0.0020) and was 100% in the high-risk group. Having an abnormal urinalysis was associated with mortality, a need for mechanical ventilation, extra-corporeal membrane oxygenation or renal replacement therapy. In conclusion, our data confirm that COVID-19-associated urine abnormalities on admission predict disease aggravation and the need for ICU (ClinicalTrials.gov number NCT04347824). MDPI 2021-07-09 /pmc/articles/PMC8306631/ /pubmed/34300217 http://dx.doi.org/10.3390/jcm10143049 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gross, Oliver Moerer, Onnen Rauen, Thomas Böckhaus, Jan Hoxha, Elion Jörres, Achim Kamm, Matthias Elfanish, Amin Windisch, Wolfram Dreher, Michael Floege, Juergen Kluge, Stefan Schmidt-Lauber, Christian Turner, Jan-Eric Huber, Samuel Addo, Marylyn M. Scheithauer, Simone Friede, Tim Braun, Gerald S. Huber, Tobias B. Blaschke, Sabine Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study |
title | Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study |
title_full | Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study |
title_fullStr | Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study |
title_full_unstemmed | Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study |
title_short | Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study |
title_sort | validation of a prospective urinalysis-based prediction model for icu resources and outcome of covid-19 disease: a multicenter cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306631/ https://www.ncbi.nlm.nih.gov/pubmed/34300217 http://dx.doi.org/10.3390/jcm10143049 |
work_keys_str_mv | AT grossoliver validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT moereronnen validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT rauenthomas validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT bockhausjan validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT hoxhaelion validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT jorresachim validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT kammmatthias validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT elfanishamin validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT windischwolfram validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT drehermichael validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT floegejuergen validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT klugestefan validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT schmidtlauberchristian validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT turnerjaneric validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT hubersamuel validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT addomarylynm validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT scheithauersimone validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT friedetim validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT braungeralds validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT hubertobiasb validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy AT blaschkesabine validationofaprospectiveurinalysisbasedpredictionmodelforicuresourcesandoutcomeofcovid19diseaseamulticentercohortstudy |